Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats

The effects of protease inhibitors on the intestinal absorption of insulin were investigated in situ in closed small and large intestinal loops in rats, and the stability of insulin was examined in homoge-nates of the small and large intestine. The intestinal absorption of insulin was evaluated by its hypoglycemic effect. When insulin alone was administered into small or large intestinal loops, no marked hypoglycemic response was observed in either region. Of the coadministered protease inhibitors, soybean trypsin inhibitor (1.5, 10 mg/ml) marginally promoted insulin absorption from the large intestine, whereas aprotinin (10 mg/ml) did to a moderate degree. However, a significant hypoglycemic effect was obtained following large intestinal administration of insulin with 20 mM of Na-glycocholate, camostat mesilate and bacitracin, when compared with the controls. In contrast, we found little hypoglycemic effect following small intestinal coadministration of insulin with these protease inhibitors. In the stability experiment, bacitracin, camostat mesilate and Na-glycocholate were effective in reducing insulin degradation in both small and large intestinal homogenates. It was found that the reduction in the proteolytic rate of insulin was related to the decrease in plasma glucose concentration by these protease inhibitors in the large intestine. These findings suggest that coadministration of protease inhibitors would be useful for improving the large intestinal absorption of insulin.

[1]  T Yashiki,et al.  Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: absorption by various routes and absorption enhancement. , 1982, Journal of pharmaceutical sciences.

[2]  G. S. Gordon,et al.  Nasal absorption of insulin: enhancement by hydrophobic bile salts. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Miyazaki,et al.  Effects of Proteolytic Enzyme Inhibitors on the Nasal Absorption of Vasopressin and an Analogue , 1991, Pharmaceutical Research.

[4]  R. Roth Bacitracin: an inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase. , 1981, Biochemical and biophysical research communications.

[5]  R. T. Jackson,et al.  Effect of bile salts on nasal permeability in vitro. , 1987, Journal of pharmaceutical sciences.

[6]  D. Neckers,et al.  A new approach to the oral administration of insulin and other peptide drugs. , 1986, Science.

[7]  W. Ritschel,et al.  Buccal absorption of insulin in the dog. , 1989, Research communications in chemical pathology and pharmacology.

[8]  A. Yamamoto,et al.  Improvement of Large Intestinal Absorption of Insulin by Chemical Modification with Palmitic Acid in Rats , 1992, The Journal of pharmacy and pharmacology.

[9]  T. Fujita,et al.  Development of New Lipophilic Derivatives of Tetragastrin: Physicochemical Characteristics and Intestinal Absorption of Acyl-tetragastrin Derivatives in Rats , 1993, Pharmaceutical Research.

[10]  E. Berry,et al.  The absorption of insulin from various regions of the rat intestine. , 1982, Life sciences.

[11]  D. Neckers,et al.  Vasopressin: a model for the study of effects of additives on the oral and rectal administration of peptide drugs. , 1988, Journal of pharmaceutical sciences.

[12]  Y. Takatsuka,et al.  Effect of surfactants on the nasal absorption of insulin in rats , 1981 .

[13]  A. Yamamoto,et al.  Improvement of Intestinal Absorption of Thyrotropin‐releasing Hormone by Chemical Modification with Lauric Acid , 1992, The Journal of pharmacy and pharmacology.

[14]  T. Higuchi,et al.  Enhancement of rectal absorption of insulin using salicylates in dogs , 1983, The Journal of pharmacy and pharmacology.

[15]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[16]  V. H. Lee,et al.  The ocular route for systemic insulin delivery in the albino rabbit. , 1989, The Journal of pharmacology and experimental therapeutics.

[17]  V. H. Lee,et al.  A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit. , 1992, The Journal of pharmacology and experimental therapeutics.

[18]  A. Yamamoto,et al.  Absorption Enhancement of Intrapulmonary Administered Insulin by Various Absorption Enhancers and Protease Inhibitors in Rats , 1994, The Journal of pharmacy and pharmacology.

[19]  V. H. Lee,et al.  Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide delivery from nonoral routes. , 1990, Life sciences.

[20]  M. Morishita,et al.  Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin. , 1993, Biological & pharmaceutical bulletin.

[21]  Akira Yamamoto,et al.  Penetration and enzymatic barriers to peptide and protein absorption , 1989 .

[22]  H. Merkle,et al.  The Adjuvant Effect of Bacitracin on Nasal Absorption of Gonadorelin and Buserelin in Rats , 1988, Pharmaceutical Research.